Summary
Neutralisation studies with monoclonal antibodies (mAbs) specific for early pregnancy factor (EPF) have shown it to be essential for the continuation of pregnancy in mice and the growth of some tumour cells in vitro. These studies report that the mAbs are also able to limit the growth of two murine tumour lines transplanted s. c. The development of MCA-2 tumours in CBA mice was unaffected by the injection of 1 mg anti-EPF IgM at the time of tumour cell inoculation. However, four doses of 500 µg anti-EPF, injected one dose per day for 4 days after tumour cell inoculation, significantly retarded tumour development such that no tumours were palpable on day 13. A similar dose regimen of control IgM had no effect on tumour size. Dose/response studies revealed that lower doses of anti-EPF administered after tumour cell inoculation were effective in retarding the growth of the MCA-2 tumours. The effect of anti-EPF mAb administration on the growth rate of palpable B16 tumours established s. c. in C57BL/6 mice was also determined. Tumours injected with 6 mg anti-EPF 5/341 or anti-EPF 5/333 mAbs showed significant decrease in the uptake of [3H]thymidine into tumour tissue, measured 16 h after injection. Furthermore, titration of sera for active EPF showed that a significant reduction in the EPF titre was associated with a significant inhibition of tumour DNA synthesis. Thus it appears that neutralisation of EPF retards tumour growth both in vitro and in vivo. In vitro the effects must be due to anti-EPF mAb interfering with a direct mechanism that contributes to the maintenance of cells in the active growing phase. However, in vivo host immunological mechanism that are modified to allow tumour survival may also be affected. The presence of EPF-induced suppressor factors curculating in the serum of tumour-bearing mice has been confirmed and the contribution of such factors to tumour progression must now be investigated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Athanasas-Platsis S, Quinn KA, Wong TY, Rolfe BE, Cavanagh AC, Morton H (1989) Passive immunization of pregnant mice against early pregnancy factor causes loss of embryonic viability. J Reprod Fertil 87: 495
Athanasas-Platsis S, Morton H, Dunglison GF, Kaye PL (1991) Antibodies to early pregnancy factor retard embryonic development in vivo in mice. J Reprod Fertil 92: 443
Bach JF, Dormont J, Dardenne M, Balner H (1969) In vitro rosette inhibition by anti-human ALS. Transplantation 8: 265
Burton K (1956) Studies of conditions and mechanisms of diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315
Cavanagh AC (1984) Production in vitro of mouse pregnancy factor and purification to homogeneity. J Reprod Fertil 71: 581
Cavanagh AC, Morton H, Athanasas-Platsis S, Quinn KA, Rolfe BE (1991) Identification of a putative inhibitor of early pregnancy factor in mice. J Reprod Fertil 91: 239
Cavanagh AC, Rolfe BE, Athanasas-Platsis S, Quinn KA, Morton H (1991) Relationship of early pregnancy factor, mouse embryo-conditioned medium and platelet activating factor. J Reprod Fertil 93: 355
Fidler IJ (1970) Metastasis: quantitative analysis of distribution and fate of tumour emboli labelled with125 I-5-iodo-deoxyurdine. JNCI 45: 773
Haranaka K, Satomi N, Sakurai A (1984) Anti-tumour activity of murine tumour necrosis factor (TNF) against transplanted tumours and heterotransplanted human tumours in nude mice. Int J Cancer 34: 263
Haubeck HD, Kolsch E (1985) Isolation and characterisation of in vitro and in vivo functions of a tumour-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma. J Immunol 135: 4297
Koppi TA, Halliday WJ (1983) Cellular origin of blocking factors from cultured spleen cells of tumour bearing mice Cell Immunol 76: 29
Morton H, Hegh V, Clunie GJA (1976) Studies of the rosette inhibition test in pregnant mice: evidence of immunosuppression? Proc R Soc Lond [Biol] 193: 413
Morton H, Rolfe BE, Cavanagh AC (1987) Ovum factor and early pregnancy factor. Curr Top Dev Biol 23: 73
Noonan FP, Halliday WJ, Morton H, Clunie GJA (1979) Early pregnancy factor is immunosuppresive. Nature 278: 649
Osieka R, Houchens DP, Goldin A, Johnson RK (1977) Chemotherapy of human colon cancer zenographs in athymic nude mice. Cancer 40: 2640
Quinn KA (1991) Early pregnancy factor: a novel factor involved in cellular proliferation. PhD Thesis, University of Queensland
Quinn KA, Athanasas-Platsis S, Wong TY, Rolfe BE, Cavanagh AC, Morton H (1990) Monoclonal antibodies to early pregnancy factor perturb tumour cell growth. Clin Exp Immunol 80: 100
Roitt IM (1980) Essential immunology, 4th ed. Blackwell Scientific, Oxford, (a) p 42; (b) p 226
Rolfe BE, Morton H, Cavanagh AC, Gardiner RA (1983) Detection of an early pregnancy factor-like substance in sera of patients with testicular germ-cell tumours. Am J Reprod Immunol 3: 97
Rolfe B, Cavanagh A, Forde C, Basten F, Chen C, Morton H (1984) Modified rosette inhibition test with mouse lymphocytes for detection of early pregnancy factor in human pregnancy serum. J Immunol Methods 70: 1
Rolfe BE, Cavanagh AC, Quinn KA, Morton H (1988) Identification of two suppressor factors induced by early pregnancy factor. Clin Exp Immunol 73: 219
Rolfe B, Quinn K, Athanasas S, Cavanagh A, Morton H (1989) Genetically restricted effector molecule released by human lymphocytes in response to early pregnancy factor. Immunol Cell Biol 67: 205
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quinn, K.A., Morton, H. Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours. Cancer Immunol Immunother 34, 265–271 (1992). https://doi.org/10.1007/BF01741795
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741795